CRISPR-Cas9: What led to the discovery



April 19th, 2016

The CRISPR-Cas9 technology holds great promise for improving plant and animal production, or even to cure hereditary diseases. Sylvain Moineau, researcher at Université Laval and holder of the Canada Research Chair in Bacteriophages, presents the contribution of his research to this major discovery.

Discover the use of CRISPR-Cas9 in the health sector, as well as in the associated legal and ethical issues.